SCHEMBL19084655

SCHEMBL19084655

CCN(c1cccc(Cn2ncc3ccccc32)c1)S(=O)(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
RORC P51449 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
S1PR1 P21453 1/20 0.45
HTT P42858 3/20 0.44
LMNA P02545 3/20 0.44
TSHR P16473 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
POLB P06746 2/20 0.44
RECQL P46063 1/20 0.42
GRIN1 Q05586 3/20 0.42
GRIN2B Q13224 3/20 0.42
PPARG P37231 6/20 0.42
NR3C1 P04150 1/20 0.41
HPGD P15428 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28256129 0.79 RECQL (0.63) HTTPOLBRECQLGRIN1GRIN2B
SCHEMBL19065109 0.78 CYP1A2 (0.54) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065097 0.77 HDAC8 (0.61) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065092 0.77 HDAC8 (0.58) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19281521 0.75 HDAC8 (0.59) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19099392 0.74 LMNA (0.50) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065095 0.74 LMNA (0.56) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065089 0.72 HDAC8 (0.64) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065098 0.72 HDAC8 (0.64) HDAC3HDAC11HDAC8HDAC6RORC
SCHEMBL19065099 0.72 RORC (0.54) HDAC3HDAC11HDAC8HDAC6RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170190659-A1 BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE WILMINGTON TRUST, NATIONAL ASSOCIATION 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170190659-A1 BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORy AND THE TREATMENT OF DISEASE RORB, RORA, RORC HDAC3 1493/4885HDAC11 1805/4885HDAC8 1717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.